• Eleven Biotherapeutics Inc., of Cambridge, Mass., appointed Abbie Celniker CEO. It also named Chen Schor chief business officer.

• GlobeImmune Inc., of Louisville, Colo., promoted Jeffrey Dekker to vice president of finance.

• Immune Pharmaceuticals Inc., of New York, named Alan Harris chief medical officer.

• Immunovaccine Inc., of Halifax, Nova Scotia, appointed John J. Trizzino CEO, effective Oct. 1.

• Inovio Pharmaceuticals Inc., of Blue Bell, Pa., added Thomas S. Edgington and Philip D. Greenberg to its board.

• iPierian Inc., of South San Francisco, appointed Nancy E. Stagliano CEO. Peter Van Vlasselaer will serve as executive chairman.

• Marina Biotech Inc., of Bothell, Wash., made several appointments, including Richard T. Ho as executive vice president of R&D; Philip C. Ranker as interim chief financial officer; Barry Polisky as chairman of the scientific advisory board; Michael V. Templin as senior vice president and chief technology officer; and Alan W. Dunton as consulting chief medical officer.

• Medivation Inc., of San Francisco, appointed Cheryl Cohen chief commercial officer.

• Medivir AB, of Huddinge, Sweden, made several recent appointments, including Maris Hartmanis as deputy CEO and chief operating officer; Bertil Samuelsson as chief scientific advisor; Charlotte Edenius as executive vice president of R&D; and Jens D. Kristensen as executive vice president of clinical.

• Neurologix Inc., of Fort Lee, N.J., appointed Adrian Adams chairman and CEO and added Andrew I. Koven as president and chief administrative.

• Onyx Pharmaceuticals Inc., of South San Francisco, appointed Helen Torley executive vice president and chief commercial officer.

• Orexo AB, of Uppsala, Sweden, appointed Carl-Johan Blomberg as chief financial officer. It also appointed Nikolaj Sorensen chief commercial officer, effective Oct. 1.

• OXIS International Inc., of Beverly Hills, Calif., named David Saloff CEO.

• PBS Biotech Inc., of Camarillo, Calif., named Lourie Zak chief financial officer.

• Provectus Pharmaceuticals Inc., of Knoxville, Tenn., named Craig Eagle to its corporate advisory board.